EAM Investors’s Aclaris Therapeutics ACRS Stock Holding History

EAM Investors’s Portfolio ACRS Stock Details ACRS Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$669K	Buy
2021 Q2	–	Sell
2021 Q1	$5.17M	Buy
2017 Q2	–	Sell
2017 Q1	$3.85M	Sell
2016 Q4	$3.76M	Buy
2016 Q3	$819K	Sell
2016 Q2	$668K	Buy